Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Indian Journal of Thoracic and Cardiovascular Surgery|October 17, 2024
Clinical features and prognostic factors in thymoma and thymic carcinomaDoğan Bayram, Serhat Sekmek, Mehmet Kayaalp, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
The Impact of Clinical and Morphometric Parameters on Hematopoietic Engraftment Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Germ Cell TumorsÖmer Faruk Kuzu, Nuri Karadurmuş, Ahmet Gazi Acar, et al.
Oncology Letters|March 20, 2026
CANT1 as a novel prognostic biomarker in triple-negative breast cancerDoğan Bayram, Aysel Çolak, Şefika Karabulut, et al.
Journal of Hepatocellular Carcinoma|December 25, 2025
The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective StudyDoğan Bayram, Efe Cem Erdat, Sema Nur Özsan Çelebi, et al.
Laboratory Medicine|December 20, 2021
Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal InvolvementGözde Sevgi Kart Bayram, Abdulsamet Erden, Doğan Bayram, et al.
Oncology|July 30, 2024
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric CancerGökhan Uçar, Serhat Sekmek, İrfan Karahan, et al.
Therapeutic Advances in Medical Oncology|September 3, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective studyOgur Karhan, Serdar İleri, Zuhat Urakçı, et al.
JCO Global Oncology|March 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu, et al.
International Journal of Cancer|June 29, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501)Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu, et al.
The Oncologist|September 7, 2023
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology GroupÇağlar Ünal, Abdulmunir Azizy, Senem Karabulut, et al.
Pageof 2